Sfoglia per Rivista AMERICAN JOURNAL OF HEMATOLOGY
ABO incompatibility in mismatched unrelated donor allogeneic hematopoietic cell transplantation for acute myeloid leukemia: A report from the acute leukemia working party of the EBMT
2017-01-01 Canaani, Jonathan; Savani, Bipin N.; Labopin, Myriam; Michallet, Mauricette; Craddock, Charles; Sociã©, Gerard; Volin, Lisa; Maertens, Johan A.; Crawley, Charles; Blaise, Didier; Ljungman, Per T.; Cornelissen, Jan; Russell, Nigel; Baron, Frã©dã©ric; Gorin, Norbert; Esteve, Jordi; Ciceri, Fabio; Schmid, Christoph; Giebel, Sebastian; Mohty, Mohamad; Nagler, Arnon
ANIMAL MODELS OF NEUROFERRITINOPATHY
2013-01-01 Maccarinelli, F; Asperti, M; Capoccia, S; Pagani, A; Buffoli, B; Codazzi, F; Finazzi, D; Pelizzoni, I; Cozzi, A; Strippoli, M; Politi, L; Cremona, ; Grohovaz, Fabio; Levi, SONIA MARIA ROSA; Arosio, P.
BINDING AND SUPPRESSIVE ACTIVITY OF HUMAN RECOMBINANT FERRITINS ON ERYTHROID-CELLS
1992-01-01 Fargion, S; Cappellini, Md; Fracanzani, Al; Defeo, Tm; Levi, SONIA MARIA ROSA; Arosio, P; Fiorelli, G.
CD34+ cell dose effects on clinical outcomes after T-cell replete haploidentical allogeneic hematopoietic stem cell transplantation for acute myeloid leukemia using peripheral blood stem cells. A study from the acute leukemia working Party of the European Society for blood and marrow transplantation (EBMT)
2020-01-01 Maffini, E.; Labopin, M.; Blaise, D.; Ciceri, F.; Gulbas, Z.; Deconinck, E.; Leblond, V.; Chevallier, P.; Socie, G.; Araujo, M. C.; Koc, Y.; Savani, B. N.; Gorin, N. C.; Lanza, F.; Nagler, A.; Mohty, M.
Clinical presentation and management practice of systemic mastocytosis. A survey on 460 Italian patients
2016-01-01 Pieri, Lisa; Bonadonna, Patrizia; Elena, Chiara; Papayannidis, Cristina; Grifoni, Federica Irene; Rondoni, Michela; Girlanda, Stefania; Mauro, Marina; Magliacane, Diomira; Elli, Elena Maria; Iorno, Maria Loredana; Almerigogna, Fabio; Scarfì, Federica; Salerno, Roberto; Fanelli, Tiziana; Gesullo, Francesca; Corbizi Fattori, Giuditta; Bonifacio, Massimiliano; Perbellini, Omar; Artuso, Anna; Soverini, Simona; De Benedittis, Caterina; Muratori, Simona; Pravettoni, Valerio; Cova, Vittoria; Cortellini, Gabriele; Ciceri, Fabio; Cortelezzi, Agostino; Martinelli, Giovanni; Triggiani, Massimo; Merante, Serena; Vannucchi, Alessandro Maria; Zanotti, Roberta
Comparable outcomes of haploidentical, 10/10 and 9/10 unrelated donor transplantation in adverse karyotype AML in first complete remission
2018-01-01 Lorentino, Francesca; Labopin, Myriam; Bernardi, Massimo; Ciceri, Fabio; Socié, Gerard; Cornelissen, Jan J.; Esteve, Jordi; Ruggeri, Annalisa; Volin, Liisa; Yacoub-Agha, Ibrahim; Craddock, Charles; Passweg, Jacob; Blaise, Didier; Gedde-Dahl, Tobias; Poiani, Monica; Fegueux, Nathalie; Mohty, Mohamad; Nagler, Arnon
Complex karyotype but not other cytogenetic abnormalities is associated with worse posttransplant survival of patients with nucleophosmin 1-mutated acute myeloid leukemia: A study from the European Society for Blood and Marrow Transplantation Acute Leukemia Working Party
2024-01-01 Moukalled, N.; Labopin, M.; Versluis, J.; Socie, G.; Blaise, D.; Salmenniemi, U.; Rambaldi, A.; Gedde-Dahl, T.; Tholouli, E.; Kroger, N.; Bourhis, J. -H.; Von Dem Borne, P.; Daguindau, E.; Forcade, E.; Nagler, A.; Esteve, J.; Ciceri, F.; Bazarbachi, A.; Mohty, M.
Continuous treatment with Ibrutinib in 100 untreated patients with TP53 disrupted chronic lymphocytic leukemia: A real-life campus CLL study
2021-01-01 Visentin, A.; Mauro, F. R.; Cibien, F.; Vitale, C.; Reda, G.; Fresa, A.; Ciolli, S.; Pietrasanta, D.; Marchetti, M.; Murru, R.; Gentile, M.; Rigolin, G. M.; Quaglia, F. M.; Scarfo', L.; Sportoletti, P.; Pravato, S.; Piazza, F.; Coscia, M.; Laurenti, L.; Molica, S.; Foa, R.; Cuneo, A.; Trentin, L.
Continuous venetoclax in treatment-naive TP53 disrupted patients with chronic lymphocytic leukemia: A chronic lymphocytic leukemia campus study
2023-01-01 Visentin, A.; Mauro, F. R.; Scarfo, L.; Gentile, M.; Farina, L.; Reda, G.; Ferrarini, I.; Proietti, G.; Derenzini, E.; Cibien, F.; Vitale, C.; Sanna, A.; Pietrasanta, D.; Marchetti, M.; Murru, R.; Rigolin, G. M.; Sportoletti, P.; Trimarco, V.; Cavarretta, C. A.; Angotzi, F.; Cellini, A.; Ruocco, V.; Zatta, I.; Laurenti, L.; Molica, S.; Coscia, M.; Ghia, P.; Foa, R.; Cuneo, A.; Trentin, L.
Elderly patients > 65 years of age with acute myeloid leukemia and normal karyotype benefit from intensive therapeutic programs
2016-01-01 Bernardi, Massimo; Carrabba, Matteo; Messina, Carlo; Milani, Raffaella; Sala, Elisa; Pavesi, Francesca; Gentner, Bernhard; Peccatori, Jacopo; Assanelli, Andrea; Marktel, Sarah; Corti, Consuelo; Forcina, Alessandra; Vago, Luca; Ciceri, Fabio
The evolving landscape of COVID-19 and post-COVID condition in patients with chronic lymphocytic leukemia: A study by ERIC, the European research initiative on CLL
2023-01-01 Visentin, A.; Chatzikonstantinou, T.; Scarfo', L.; Kapetanakis, A.; Demosthenous, C.; Karakatsoulis, G.; Minga, E.; Chamou, D.; Allsup, D.; Cabrero, A. A.; Andres, M.; Antic, D.; Baile, M.; Baliakas, P.; Besikli-Dimou, S.; Bron, D.; Chatzileontiadou, S.; Cordoba, R.; Correa, J. -G.; Cuellar-Garcia, C.; De Paoli, L.; De Paolis, M. R.; Delgado, J.; Dimou, M.; Donaldson, D.; Catherwood, M.; Doubek, M.; Efstathopoulou, M.; Eichhorst, B.; Elashwah, S.; Enrico, A.; Espinet, B.; Farina, L.; Ferrari, A.; Foglietta, M.; Frederiksen, H.; Furstenau, M.; Garcia-Marco, J. A.; Garcia-Serra, R.; Collado, R.; Gentile, M.; Gimeno, E.; Glenthoj, A.; da Silva, M. G.; Hakobyan, Y. K.; Herishanu, Y.; Hernandez-Rivas, J. A.; Herold, T.; Innocenti, I.; Itchaki, G.; Jaksic, O.; Janssens, A.; Kalashnikova, О. B.; Kalicinska, E.; Kater, A. P.; Kersting, S.; Labrador, J.; Lad, D.; Laurenti, L.; Levin, M. -D.; Lista, E.; Lopez-Garcia, A.; Malerba, L.; Marasca, R.; Marchetti, M.; Marquet, J.; Mattsson, M.; Mauro, F. R.; Morawska, M.; Motta, M.; Munir, T.; Murru, R.; Niemann, C. U.; Rodrigues, R. N.; Olivieri, J.; Orsucci, L.; Papaioannou, M.; Pavlovsky, M. A.; Piskunova, I.; Popov, V. M.; Quaglia, F. M.; Quaresmini, G.; Qvist, K.; Rigolin, G. M.; Ruchlemer, R.; Simkovic, M.; Spacek, M.; Sportoletti, P.; Stanca, O.; Tadmor, T.; Capasso, A.; Del Poeta, G.; Gutwein, O.; Karlsson, L. K.; Milosevic, I.; Miras, F.; Reda, G.; Saghumyan, G.; Shrestha, A.; Te Raa, D.; Tonino, S. H.; Van Der Spek, E.; van Gelder, M.; van Kampen, R.; Wasik-Szczepanek, E.; Wrobel, T.; Segundo, L. Y. S.; Yassin, M.; Pocali, B.; Vandenberghe, E.; Iyengar, S.; Varettoni, M.; Vitale, C.; Coscia, M.; Rambaldi, A.; Montserrat, E.; Cuneo, A.; Stavroyianni, N.; Trentin, L.; Stamatopoulos, K.; Ghia, P.
EXPLOITING IRON TOXICITY IN MULTIPLE MYELOMA: A STRATEGY TO INCREASE THE EFFICACY OF PROTEASOME INHIBITION THERAPIES
2013-01-01 Campanella, A; Bertilaccio, S; Santambrogio, P; Marcatti, M; Sitia, R; Tonon, G; Camaschella, C
Frontline treatment with the combination obinutuzumab ± chlorambucil for chronic lymphocytic leukemia outside clinical trials: Results of a multinational, multicenter study by ERIC and the Israeli CLL study group
2020-01-01 Herishanu, Y.; Shaulov, A.; Fineman, R.; Basic-Kinda, S.; Aviv, A.; Wasik-Szczepanek, E.; Jaksic, O.; Zdrenghea, M.; Greenbaum, U.; Mandac, I.; Simkovic, M.; Morawska, M.; Benjamini, O.; Spacek, M.; Nemets, A.; Bairey, O.; Trentin, L.; Ruchlemer, R.; Laurenti, L.; Stanca Ciocan, O.; Doubek, M.; Shvidel, L.; Dali, N.; Miras, F.; De Meuter, A.; Dimou, M.; Mauro, F. R.; Coscia, M.; Bumbea, H.; Szasz, R.; Tadmor, T.; Gutwein, O.; Gentile, M.; Scarfo', L.; Tedeschi, A.; Sportoletti, P.; Gimeno Vazquez, E.; Marquet, J.; Assouline, S.; Papaioannou, M.; Braester, A.; Levato, L.; Gregor, M.; Rigolin, G. M.; Loscertales, J.; Medina Perez, A.; Nijziel, M. R.; Popov, V. M.; Collado, R.; Slavutsky, I.; Itchaki, G.; Ringelstein, S.; Goldschmidt, N.; Perry, C.; Levi, S.; Polliack, A.; Ghia, P.
Haploidentical transplantation outcomes for secondary acute myeloid leukemia: Acute Leukemia Working Party (ALWP) of the European Society for Blood and Marrow Transplantation (EBMT) study
2018-01-01 Li, Zhuoyan; Labopin, Myriam; Ciceri, Fabio; Blaise, Didier; Tischer, Johanna; Ehninger, Gerhard; Van Lint, M. T.; Koc, Yener; Santarone, Stella; Forcade, Edouard; Castagna, Luca; Polge, Emmanuelle; Mailhol, Audrey; Ruggeri, Annalisa; Mohty, Mohamad; Savani, Bipin N.; Nagler, Arnon
Hepcidin levels predict Covid-19 severity and mortality in a cohort of hospitalized Italian patients
2021-01-01 Nai, A; Lore, Ni; Pagani, A; De Lorenzo, R; Di Modica, S; Saliu, F; Cirillo, Dm; Rovere-Querini, P; Manfredi, Aa; Silvestri, L
Human leukocyte antigen-haploidentical transplantation for relapsed/refractory acute myeloid leukemia: Better leukemia-free survival with bone marrow than with peripheral blood stem cells in patients ≥55 years of age
2022-01-01 Baron, Frédéric; Labopin, Myriam; Tischer, Johanna; Ciceri, Fabio; Raiola, Anna Maria; Blaise, Didier; Sica, Simona; Vydra, Jan; Fanin, Renato; Stölzel, Friedrich; Busca, Alessandro; Diez-Martin, Jose Luis; Koc, Yener; Nagler, Arnon; Mohty, Mohamad
Impact of total body irradiation- vs chemotherapy-based myeloablative conditioning on outcomes of haploidentical hematopoietic cell transplantation for acute myelogenous leukemia
2020-01-01 Dholaria, B.; Labopin, M.; Angelucci, E.; Ciceri, F.; Diez-Martin, J. L.; Bruno, B.; Sica, S.; Koc, Y.; Gulbas, Z.; Schmid, C.; Blaise, D.; Carella, A. M.; Visani, G.; Savani, B. N.; Nagler, A.; Mohty, M.
IRON UPTAKE IN RESTING AND REACTIVE ASTROCYTES: A POTENTIALLY NEUROPROTECTIVE CONTROL OF IRON BURDEN
2013-01-01 Pelizzoni, I; Zacchetti, D; Campanella, A; Macco, R; Consonni, A; Bettegazzi, B; Grohovaz, Fabio; Codazzi, F.
Lower relapse incidence with haploidentical versus matched sibling or unrelated donor hematopoietic cell transplantation for core-binding factor AML patients in CR2: A study from the Global Committee and the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation
2024-01-01 Ye, Y.; Labopin, M.; Gerard, S.; Yakoub-Agha, I.; Blau, I. W.; Aljurf, M.; Forcade, E.; Gedde-Dahl, T.; Burns, D.; Vydra, J.; Halahleh, K.; Hamladji, R. -M.; Bazarbachi, A.; Nagler, A.; Brissot, E.; Li, L.; Luo, Y.; Zhao, Y.; Ciceri, F.; Huang, H.; Mohty, M.; Gorin, N. C.
A matching-adjusted indirect comparison of acalabrutinib versus zanubrutinib in relapsed or refractory chronic lymphocytic leukemia
2023-01-01 Kittai, A. S.; Skarbnik, A.; Miranda, M.; Yong, A. S. M.; Roos, J.; Hettle, R.; Palazuelos-Munoz, S.; Shetty, V.; Ghia, P.
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| ABO incompatibility in mismatched unrelated donor allogeneic hematopoietic cell transplantation for acute myeloid leukemia: A report from the acute leukemia working party of the EBMT | 1-gen-2017 | Canaani, Jonathan; Savani, Bipin N.; Labopin, Myriam; Michallet, Mauricette; Craddock, Charles; Sociã©, Gerard; Volin, Lisa; Maertens, Johan A.; Crawley, Charles; Blaise, Didier; Ljungman, Per T.; Cornelissen, Jan; Russell, Nigel; Baron, Frã©dã©ric; Gorin, Norbert; Esteve, Jordi; Ciceri, Fabio; Schmid, Christoph; Giebel, Sebastian; Mohty, Mohamad; Nagler, Arnon | |
| ANIMAL MODELS OF NEUROFERRITINOPATHY | 1-gen-2013 | Maccarinelli, F; Asperti, M; Capoccia, S; Pagani, A; Buffoli, B; Codazzi, F; Finazzi, D; Pelizzoni, I; Cozzi, A; Strippoli, M; Politi, L; Cremona, ; Grohovaz, Fabio; Levi, SONIA MARIA ROSA; Arosio, P. | |
| BINDING AND SUPPRESSIVE ACTIVITY OF HUMAN RECOMBINANT FERRITINS ON ERYTHROID-CELLS | 1-gen-1992 | Fargion, S; Cappellini, Md; Fracanzani, Al; Defeo, Tm; Levi, SONIA MARIA ROSA; Arosio, P; Fiorelli, G. | |
| CD34+ cell dose effects on clinical outcomes after T-cell replete haploidentical allogeneic hematopoietic stem cell transplantation for acute myeloid leukemia using peripheral blood stem cells. A study from the acute leukemia working Party of the European Society for blood and marrow transplantation (EBMT) | 1-gen-2020 | Maffini, E.; Labopin, M.; Blaise, D.; Ciceri, F.; Gulbas, Z.; Deconinck, E.; Leblond, V.; Chevallier, P.; Socie, G.; Araujo, M. C.; Koc, Y.; Savani, B. N.; Gorin, N. C.; Lanza, F.; Nagler, A.; Mohty, M. | |
| Clinical presentation and management practice of systemic mastocytosis. A survey on 460 Italian patients | 1-gen-2016 | Pieri, Lisa; Bonadonna, Patrizia; Elena, Chiara; Papayannidis, Cristina; Grifoni, Federica Irene; Rondoni, Michela; Girlanda, Stefania; Mauro, Marina; Magliacane, Diomira; Elli, Elena Maria; Iorno, Maria Loredana; Almerigogna, Fabio; Scarfì, Federica; Salerno, Roberto; Fanelli, Tiziana; Gesullo, Francesca; Corbizi Fattori, Giuditta; Bonifacio, Massimiliano; Perbellini, Omar; Artuso, Anna; Soverini, Simona; De Benedittis, Caterina; Muratori, Simona; Pravettoni, Valerio; Cova, Vittoria; Cortellini, Gabriele; Ciceri, Fabio; Cortelezzi, Agostino; Martinelli, Giovanni; Triggiani, Massimo; Merante, Serena; Vannucchi, Alessandro Maria; Zanotti, Roberta | |
| Comparable outcomes of haploidentical, 10/10 and 9/10 unrelated donor transplantation in adverse karyotype AML in first complete remission | 1-gen-2018 | Lorentino, Francesca; Labopin, Myriam; Bernardi, Massimo; Ciceri, Fabio; Socié, Gerard; Cornelissen, Jan J.; Esteve, Jordi; Ruggeri, Annalisa; Volin, Liisa; Yacoub-Agha, Ibrahim; Craddock, Charles; Passweg, Jacob; Blaise, Didier; Gedde-Dahl, Tobias; Poiani, Monica; Fegueux, Nathalie; Mohty, Mohamad; Nagler, Arnon | |
| Complex karyotype but not other cytogenetic abnormalities is associated with worse posttransplant survival of patients with nucleophosmin 1-mutated acute myeloid leukemia: A study from the European Society for Blood and Marrow Transplantation Acute Leukemia Working Party | 1-gen-2024 | Moukalled, N.; Labopin, M.; Versluis, J.; Socie, G.; Blaise, D.; Salmenniemi, U.; Rambaldi, A.; Gedde-Dahl, T.; Tholouli, E.; Kroger, N.; Bourhis, J. -H.; Von Dem Borne, P.; Daguindau, E.; Forcade, E.; Nagler, A.; Esteve, J.; Ciceri, F.; Bazarbachi, A.; Mohty, M. | |
| Continuous treatment with Ibrutinib in 100 untreated patients with TP53 disrupted chronic lymphocytic leukemia: A real-life campus CLL study | 1-gen-2021 | Visentin, A.; Mauro, F. R.; Cibien, F.; Vitale, C.; Reda, G.; Fresa, A.; Ciolli, S.; Pietrasanta, D.; Marchetti, M.; Murru, R.; Gentile, M.; Rigolin, G. M.; Quaglia, F. M.; Scarfo', L.; Sportoletti, P.; Pravato, S.; Piazza, F.; Coscia, M.; Laurenti, L.; Molica, S.; Foa, R.; Cuneo, A.; Trentin, L. | |
| Continuous venetoclax in treatment-naive TP53 disrupted patients with chronic lymphocytic leukemia: A chronic lymphocytic leukemia campus study | 1-gen-2023 | Visentin, A.; Mauro, F. R.; Scarfo, L.; Gentile, M.; Farina, L.; Reda, G.; Ferrarini, I.; Proietti, G.; Derenzini, E.; Cibien, F.; Vitale, C.; Sanna, A.; Pietrasanta, D.; Marchetti, M.; Murru, R.; Rigolin, G. M.; Sportoletti, P.; Trimarco, V.; Cavarretta, C. A.; Angotzi, F.; Cellini, A.; Ruocco, V.; Zatta, I.; Laurenti, L.; Molica, S.; Coscia, M.; Ghia, P.; Foa, R.; Cuneo, A.; Trentin, L. | |
| Elderly patients > 65 years of age with acute myeloid leukemia and normal karyotype benefit from intensive therapeutic programs | 1-gen-2016 | Bernardi, Massimo; Carrabba, Matteo; Messina, Carlo; Milani, Raffaella; Sala, Elisa; Pavesi, Francesca; Gentner, Bernhard; Peccatori, Jacopo; Assanelli, Andrea; Marktel, Sarah; Corti, Consuelo; Forcina, Alessandra; Vago, Luca; Ciceri, Fabio | |
| The evolving landscape of COVID-19 and post-COVID condition in patients with chronic lymphocytic leukemia: A study by ERIC, the European research initiative on CLL | 1-gen-2023 | Visentin, A.; Chatzikonstantinou, T.; Scarfo', L.; Kapetanakis, A.; Demosthenous, C.; Karakatsoulis, G.; Minga, E.; Chamou, D.; Allsup, D.; Cabrero, A. A.; Andres, M.; Antic, D.; Baile, M.; Baliakas, P.; Besikli-Dimou, S.; Bron, D.; Chatzileontiadou, S.; Cordoba, R.; Correa, J. -G.; Cuellar-Garcia, C.; De Paoli, L.; De Paolis, M. R.; Delgado, J.; Dimou, M.; Donaldson, D.; Catherwood, M.; Doubek, M.; Efstathopoulou, M.; Eichhorst, B.; Elashwah, S.; Enrico, A.; Espinet, B.; Farina, L.; Ferrari, A.; Foglietta, M.; Frederiksen, H.; Furstenau, M.; Garcia-Marco, J. A.; Garcia-Serra, R.; Collado, R.; Gentile, M.; Gimeno, E.; Glenthoj, A.; da Silva, M. G.; Hakobyan, Y. K.; Herishanu, Y.; Hernandez-Rivas, J. A.; Herold, T.; Innocenti, I.; Itchaki, G.; Jaksic, O.; Janssens, A.; Kalashnikova, О. B.; Kalicinska, E.; Kater, A. P.; Kersting, S.; Labrador, J.; Lad, D.; Laurenti, L.; Levin, M. -D.; Lista, E.; Lopez-Garcia, A.; Malerba, L.; Marasca, R.; Marchetti, M.; Marquet, J.; Mattsson, M.; Mauro, F. R.; Morawska, M.; Motta, M.; Munir, T.; Murru, R.; Niemann, C. U.; Rodrigues, R. N.; Olivieri, J.; Orsucci, L.; Papaioannou, M.; Pavlovsky, M. A.; Piskunova, I.; Popov, V. M.; Quaglia, F. M.; Quaresmini, G.; Qvist, K.; Rigolin, G. M.; Ruchlemer, R.; Simkovic, M.; Spacek, M.; Sportoletti, P.; Stanca, O.; Tadmor, T.; Capasso, A.; Del Poeta, G.; Gutwein, O.; Karlsson, L. K.; Milosevic, I.; Miras, F.; Reda, G.; Saghumyan, G.; Shrestha, A.; Te Raa, D.; Tonino, S. H.; Van Der Spek, E.; van Gelder, M.; van Kampen, R.; Wasik-Szczepanek, E.; Wrobel, T.; Segundo, L. Y. S.; Yassin, M.; Pocali, B.; Vandenberghe, E.; Iyengar, S.; Varettoni, M.; Vitale, C.; Coscia, M.; Rambaldi, A.; Montserrat, E.; Cuneo, A.; Stavroyianni, N.; Trentin, L.; Stamatopoulos, K.; Ghia, P. | |
| EXPLOITING IRON TOXICITY IN MULTIPLE MYELOMA: A STRATEGY TO INCREASE THE EFFICACY OF PROTEASOME INHIBITION THERAPIES | 1-gen-2013 | Campanella, A; Bertilaccio, S; Santambrogio, P; Marcatti, M; Sitia, R; Tonon, G; Camaschella, C | |
| Frontline treatment with the combination obinutuzumab ± chlorambucil for chronic lymphocytic leukemia outside clinical trials: Results of a multinational, multicenter study by ERIC and the Israeli CLL study group | 1-gen-2020 | Herishanu, Y.; Shaulov, A.; Fineman, R.; Basic-Kinda, S.; Aviv, A.; Wasik-Szczepanek, E.; Jaksic, O.; Zdrenghea, M.; Greenbaum, U.; Mandac, I.; Simkovic, M.; Morawska, M.; Benjamini, O.; Spacek, M.; Nemets, A.; Bairey, O.; Trentin, L.; Ruchlemer, R.; Laurenti, L.; Stanca Ciocan, O.; Doubek, M.; Shvidel, L.; Dali, N.; Miras, F.; De Meuter, A.; Dimou, M.; Mauro, F. R.; Coscia, M.; Bumbea, H.; Szasz, R.; Tadmor, T.; Gutwein, O.; Gentile, M.; Scarfo', L.; Tedeschi, A.; Sportoletti, P.; Gimeno Vazquez, E.; Marquet, J.; Assouline, S.; Papaioannou, M.; Braester, A.; Levato, L.; Gregor, M.; Rigolin, G. M.; Loscertales, J.; Medina Perez, A.; Nijziel, M. R.; Popov, V. M.; Collado, R.; Slavutsky, I.; Itchaki, G.; Ringelstein, S.; Goldschmidt, N.; Perry, C.; Levi, S.; Polliack, A.; Ghia, P. | |
| Haploidentical transplantation outcomes for secondary acute myeloid leukemia: Acute Leukemia Working Party (ALWP) of the European Society for Blood and Marrow Transplantation (EBMT) study | 1-gen-2018 | Li, Zhuoyan; Labopin, Myriam; Ciceri, Fabio; Blaise, Didier; Tischer, Johanna; Ehninger, Gerhard; Van Lint, M. T.; Koc, Yener; Santarone, Stella; Forcade, Edouard; Castagna, Luca; Polge, Emmanuelle; Mailhol, Audrey; Ruggeri, Annalisa; Mohty, Mohamad; Savani, Bipin N.; Nagler, Arnon | |
| Hepcidin levels predict Covid-19 severity and mortality in a cohort of hospitalized Italian patients | 1-gen-2021 | Nai, A; Lore, Ni; Pagani, A; De Lorenzo, R; Di Modica, S; Saliu, F; Cirillo, Dm; Rovere-Querini, P; Manfredi, Aa; Silvestri, L | |
| Human leukocyte antigen-haploidentical transplantation for relapsed/refractory acute myeloid leukemia: Better leukemia-free survival with bone marrow than with peripheral blood stem cells in patients ≥55 years of age | 1-gen-2022 | Baron, Frédéric; Labopin, Myriam; Tischer, Johanna; Ciceri, Fabio; Raiola, Anna Maria; Blaise, Didier; Sica, Simona; Vydra, Jan; Fanin, Renato; Stölzel, Friedrich; Busca, Alessandro; Diez-Martin, Jose Luis; Koc, Yener; Nagler, Arnon; Mohty, Mohamad | |
| Impact of total body irradiation- vs chemotherapy-based myeloablative conditioning on outcomes of haploidentical hematopoietic cell transplantation for acute myelogenous leukemia | 1-gen-2020 | Dholaria, B.; Labopin, M.; Angelucci, E.; Ciceri, F.; Diez-Martin, J. L.; Bruno, B.; Sica, S.; Koc, Y.; Gulbas, Z.; Schmid, C.; Blaise, D.; Carella, A. M.; Visani, G.; Savani, B. N.; Nagler, A.; Mohty, M. | |
| IRON UPTAKE IN RESTING AND REACTIVE ASTROCYTES: A POTENTIALLY NEUROPROTECTIVE CONTROL OF IRON BURDEN | 1-gen-2013 | Pelizzoni, I; Zacchetti, D; Campanella, A; Macco, R; Consonni, A; Bettegazzi, B; Grohovaz, Fabio; Codazzi, F. | |
| Lower relapse incidence with haploidentical versus matched sibling or unrelated donor hematopoietic cell transplantation for core-binding factor AML patients in CR2: A study from the Global Committee and the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation | 1-gen-2024 | Ye, Y.; Labopin, M.; Gerard, S.; Yakoub-Agha, I.; Blau, I. W.; Aljurf, M.; Forcade, E.; Gedde-Dahl, T.; Burns, D.; Vydra, J.; Halahleh, K.; Hamladji, R. -M.; Bazarbachi, A.; Nagler, A.; Brissot, E.; Li, L.; Luo, Y.; Zhao, Y.; Ciceri, F.; Huang, H.; Mohty, M.; Gorin, N. C. | |
| A matching-adjusted indirect comparison of acalabrutinib versus zanubrutinib in relapsed or refractory chronic lymphocytic leukemia | 1-gen-2023 | Kittai, A. S.; Skarbnik, A.; Miranda, M.; Yong, A. S. M.; Roos, J.; Hettle, R.; Palazuelos-Munoz, S.; Shetty, V.; Ghia, P. |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile